Background: During acellular replacement of an acute blood loss, hyperoxic ventilation (HV) increases the amount of O 2 physically dissolved in the plasma and thereby improves O 2 supply to the tissues. While this effect could be demonstrated for HV with inspiratory O 2 fraction (FiO 2 ) 0.6, it was unclear whether HV with pure oxygen (FiO 2 1.0) would have an additional effect on the physiological limit of acute normovolemic anemia. Methods: Seven anesthetized domestic pigs were ventilated with FiO 2 1.0 and subjected to an isovolemic hemodilution protocol. Blood was drawn and replaced by a 6% hydroxyethyl starch (HES) solution (130/0.4) until a sudden decrease of total body O 2 consumption (VO 2 ) indicated the onset of O 2 supply dependency (primary endpoint). The corresponding hemoglobin (Hb) concentration was defined as 'critical Hb' (Hb crit ). Secondary endpoints were parameters of myocardial function, central hemodynamics, O 2 transport and tissue oxygenation. Results: HV with FiO 2 1.0 enabled a large blood-for-HES exchange (156 ± 28% of the circulating blood volume) until Hb crit was met at 1.3 ± 0.3 g/dl. After termination of the hemodilution protocol, the contribution of O 2 physically dissolved in the plasma to O 2 delivery and VO 2 had significantly increased from 11.7 ± 2 to 44.2 ± 9.7% and from 29.1 ± 4.2 to 66.2 ± 11.7%, respectively. However, at Hb crit , cardiovascular performance was found to have severely deteriorated. Conclusion: HV with FiO 2 1.0 maintains O 2 supply to tissues during extensive blood-for-HES exchange. In acute situations, where profound anemia must be tolerated (e.g. bridging an acute blood loss until red blood cells become available for transfusion), O 2 physically dissolved in the plasma becomes an essential source of oxygen. However, compromised cardiovascular performance might require additional treatment.
Introduction
The initial treatment of an acute blood loss usually consists in the infusion of crystalloid and/or colloidal fluids. However, the restoration of normovolemia with acellular fluids leads to a dilution of the red cell mass remaining in the vasculature (acute normovolemic anemia). In this context, the term 'anemia tolerance' refers both to the patient's physiological condition to tolerate acute anemia and the physician's readiness to accept low hemoglobin (Hb) values (e.g. during restrictive transfusion regimes) [1] .
Although O 2 transport capacity decreases progressively with hemodilution, tissue oxygenation can be sustained over a wide range of decreasing Hb concentrations [2] . First, acute normovolemic anemia is compensated by increases in cardiac output and arteriovenous O 2 extraction (O 2 ER) [3] so that O 2 delivery (DO 2 ) to the tissues and O 2 consumption (VO 2 ) remain constant. Second, at physiologic Hb concentrations, DO 2 exceeds VO 2 by the factor 3-4 [4] . Therefore, O 2 supply to the tissues is still sufficient to meet their O 2 demand even when DO 2 begins to decrease at lower Hb concentrations (supply independency of VO 2 ; fig. 1 ).
When DO 2 falls below the value of VO 2 , O 2 metabolism becomes dependent on DO 2 and VO 2 starts to decline (supply dependency of VO 2 [5, 6] ). The Hb concentration corresponding to the sudden decrease in VO 2 is called 'critical Hb' (Hb crit ) and reflects the individual limit of anemia tolerance [1] .
Hyperoxic ventilation (HV) provides a simple but effective possibility to improve O 2 supply to the tissues, when the number of circulating red blood cells becomes insufficient to meet total-body O 2 demand. In a previous study, we could already demonstrate that the institution of HV with inspiratory O 2 fraction (FiO 2 ) 0.6 prior to induction of acute normovolemic anemia allowed for hemodilution to lower values of Hb crit than did ventilation with ambient air [7] . However, the question remained open whether using pure oxygen could additionally increase anemia tolerance. We therefore hypothesized that HV with FiO 2 1.0 allows for a more extensive hemodilution, even resulting in a lower value of Hb crit than HV with FiO 2 0.6.
Materials and Methods
With the approval of the governmental review board (approval code V54-19c 20/15-91/30), experiments were performed in 7 healthy farm-bred pigs of either sex (body weight 29.8 ± 3.7 kg). All animals received good care in compliance with the Guide for the Care and Use of Laboratory Animals .
Anesthesia and Ventilation
Twelve hours before the experiments, the animals were denied food but had free access to water. After i.m. premedication with 10 mg/kg ketamine and 1 mg/kg midazolam, anesthesia was induced by i.v. injection of fentanyl (20 μg/kg) and propofol (1.5 mg/kg) and maintained by continuous infusion of midazolam (0.01 mg/kg/min), propofol (0.16 mg/kg/min) and fentanyl (0.8 μg/kg/min). To facilitate intubation, animals were paralyzed by a bolus injection of pancuronium (0.2 mg/kg). For adequate assessment of oxygen tension (tpO 2 ) on the surface of a skeletal muscle (see below), neuromuscular blockade (NMB) was maintained by continuous infusion of pancuronium (0.12 mg/min). Estimated fluid losses (particularly including insensible perspiration owing to the open-chest model, see below) were replaced by a balanced electrolyte solution (0.25 ml/kg/min). All trade names of anesthetics and infusion fluids used are listed in the Appendix.
After orotracheal intubation, animals were ventilated using the CMV mode (controlled mandatory ventilation; 12 cycles/min, PEEP 5 cm H 2 O; Vela Ventilator, Viasys Healthcare, Höchberg, Germany). Based on repeated blood gas analyses, tidal volume was adjusted to provide arterial normocapnia and was then maintained throughout the entire protocol. Until the end of surgical preparation, all animals were ventilated with ambient air.
Instrumentation and Monitoring
All animals were placed in supine position. A 5-lead electrocardiogram (II, V5) was installed for detection of arrhythmias and ST segment changes. Animals were instrumented with 2 electronic tip manometer catheters (PC 370, Millar Instruments, Houston, Tex., USA) placed in the abdominal part of the aorta and in the left ventricle. A double-lumen catheter (Arrow, Reading, Pa., USA) was inserted into the superior vena cava, and a Swan-Ganz catheter (right ventricular ejection fraction/volumetric catheter, Baxter, Irvine, Calif., USA) was floated into a branch of the pulmonary artery. After midline sternotomy and opening of the pericardium, an ultrasonic flow probe (diameter 14 mm; Transonic Systems, Ithaca, N.Y., USA) was placed around the root of the aorta for continuous measurement of cardiac output. The left anterior descending coronary artery (LAD) was dissected free from surrounding tissue, and an additional ultrasonic flow probe (diameter 2 mm; Transonic Systems) was implanted for assessment of coronary blood flow. For withdrawal of coronary venous blood samples, the anterior interventricular vein was cannulated with an 18-gauge Teflon catheter (Leader Cath, Vygon, Ecouen, France). A large-bore hemodialysis catheter and a 7-French introducer sheath (both by Arrow) were inserted into the left femoral vein and into the right femoral artery for withdrawal of blood and isovolemic infusion of hydroxyethyl starch (HES), respectively. Via a mini-laparotomy, a Foley catheter (Rüsch, Kernen, Germany) was inserted into the urinary bladder. An area of 3 × 5 cm of the anterior rectus abdominis muscle was dissected free from surrounding tissue for measurement of tpO 2 . Body temperature was kept constant using a warming pad and a warming lamp.
Experimental Protocol
After completion of surgical preparation and installation of the different measuring devices, FiO 2 was increased to 1.0 and a new calibration of the Oxycon Pro TM device (Viasys Healthcare) was performed with pure oxygen. Subsequently, a 60-min stabilization period was allowed to elapse to achieve stable baseline conditions.
The baseline data set was recorded, and subsequently, acute normovolemic anemia was induced by simultaneous exchange of blood for 6% tetrastarch (HES 130/0.4, exchange rate 1 ml/kg/min). The target parameter was the animal's individual Hb crit . When this target was met, a second set of data was collected. Subsequently, animals were killed by intracardial injection of saturated potassium solution.
Determination of Hb crit
Hb crit is the correlate of the critical limitation of DO 2 and marks the onset of total body O 2 supply dependency ( fig. 1 ). The corresponding decrease of VO 2 was detected in an automated and investigator-independent manner: VO 2 was measured with an ergospirometer (Oxycon Pro). VO 2 values were recorded and computed with a specific software (DeltaCrit System, DCS) [8] figure 2 .
Measurements
Blood volume was determined at baseline and at the individual Hb crit (Hb crit -1.0) using the 'whole-blood' method of the indocyanine green indicator dilution technique, which has already been described in detail elsewhere [9] . The pressure transducers and flowmeters of the hemodynamic measurement devices were connected with a multichannel recorder (Hugo Sachs, March-Hugstetten, Germany) and measurement readings were recorded with a personal computer. The indices of cardiac output (cardiac index, CI) and systemic vascular resistance index (SVRI) as well as pulmonary vascular resistance index (PVRI) were calculated relative to body surface area (see Appendix).
Arterial, mixed venous and coronary venous blood samples were drawn at baseline and at Hb crit -1.0 for blood gas analysis (ABL 300, Radiometer, Copenhagen, Denmark) and assessment of Hb concentration (682 CO-Oximeter, Instrumentation Laboratory, Lexington, Mass., USA).
During the hemodilution period, arterial and mixed venous blood samples were drawn after every 200 ml of blood exchange. Hemodynamic parameters were registered continuously with the laboratory setup.
For comparison with the results of our previous study, 2 additional data sets corresponding to Hb ∼ 2.4 g/dl (Hb crit -0.21, i.e. Hb crit in animals ventilated with FiO 2 0.21) and Hb ∼ 1.6 g/dl (Hb crit -0.6, i.e. Hb crit in animals ventilated with FiO 2 0.6) were retrospectively read out from the continuous recordings. tpO 2 on the surface of the skeletal muscle was determined at baseline and at Hb crit -1.0 using 2 multiwire platinum surface electrodes (MDO-Electrode, Eschweiler, Kiel, Germany) connected with a microprocessor system (Ingenieurbüro Mussler, Aachen, Germany). After equilibration with the tissue surface, this method enables exact assessment of tpO 2 [10] . With each measurement, 240 individual tpO 2 values were recorded; the location of the electrodes on the muscle surface was changed 3-5 times each.
Statistics
Statistical analysis was performed using the SAS 9.2 software package (SAS Institute, Cary, N.C., USA). All data are presented as means ± SD. Data distribution was assessed using Shapiro-Wilk test.
In case of normal distribution, time effects on the different variables were tested by repeated analysis of variance (ANOVA). Post hoc analysis of differences detected with ANOVA was performed with the StudentNewman-Keuls test. In case of nonnormal distribution, time effects on the parameters were tested by analysis of variance on ranks (rANOVA). Post hoc analysis of differences detected with rANOVA was performed with Tukey's test. 
Results

Primary Endpoint: Hb crit
Hemodilution to Hb crit -1.0 required the exchange of 3,749 ± 640 ml of blood for HES, corresponding with an exchange of 156 ± 28% of the circulating blood volume. Beginning with a Hb concentration of 7.7 ± 0.5 g/dl at baseline, Hb crit -1.0 was met at 1.3 ± 0.3 g/dl ( fig. 3 ). Table 1 displays secondary endpoint parameters at baseline, after hemodilution to Hb 2.4 g/dl (i.e. Hb crit -0.21) and Hb 1.6 g/dl (i.e. Hb crit -0.6), and finally at the critical Hb concentration (Hb crit -1.0).
Secondary Endpoints: Hemodynamic and O 2 -Derived Parameters
Hemodynamics and Myocardial Function
During hemodilution to Hb 2.4 g/dl, heart rate (HR) increased by 27% and increased by a further 36% during hemodilution to Hb 1.5 g/dl. At Hb crit -1.0, HR decreased to baseline level. While mean pulmonary arterial pressure remained almost unchanged during the hemodilution protocol, mean arterial pressure decreased continuously and was significantly beyond baseline level at Hb crit . Consistently, CI increased initially, while SVRI decreased by 51% during hemodilution to Hb 2.4 g/dl, by 36% during hemodilution to Hb 1.5 g/dl and by a further 37% during the final hemodilution step.
Left ventricular (LV) systolic contractility reflected by the maximal slope of LV pressure increase (dp/dt max ) increased at the beginning of the hemodilution protocol, but decreased under baseline level at Hb crit -1.0. Likewise, LV diastolic function represented by the maximum LV pressure decrease (dp/dt min ) had severely deteriorated at Hb crit -1.0. 
O 2 Transport and Tissue Oxygenation
Proportionally with the decrease in Hb concentration and arterial O 2 content (CaO 2 ), DO 2 index decreased by 38% (hemodilution to Hb 2.4 g/dl), 37% (Hb 1.5 g/dl) and 36% (Hb crit -1.0). As a compensation of acute anemia, arteriovenous O 2 ER increased with every hemodilution step, which was accompanied by a slight but constant decrease of mixed venous O 2 partial pressure (pvO 2 ).
Hemodilution markedly decreased the contribution of Hb-transported O 2 to DO 2 and VO 2 . Simultaneously, the contribution of physically dissolved O 2 to DO 2 increased from 11.7 ± 2% (baseline) to 44.2 ± 9.7% (Hb crit ; p < 0.05) and its contribution to VO 2 increased from 29.1 ± 4.3 to 66.2 ± 11.7% (p < 0.05; fig. 4 a, b) .
Despite the utilization of physically dissolved O 2 , lactate concentration was elevated above baseline level at Hb 1.5 g/dl (p < 0.05) and further increased after continuation of hemodilution to Hb crit -1.0. Consistently, base excess decreased by 90% during the first 2 hemodilution steps and by a further 34% during hemodilution from 1.5 g/dl to Hb crit . Manifest tissue hypoxia on the surface of the skeletal muscle was indicated by the typical left shift of tpO 2 sum histograms ( fig. 5 ). The median decreased from 33.8 ± 12.1 to 8 ± 6 mm Hg (p < 0.05) and the fraction of hypoxic values increased from 9 ± 4 to 64 ± 33% (p < 0.05).
Myocardial Perfusion and Oxygenation
To compensate for increased myocardial O 2 demand, coronary blood flow in the LAD increased initially by 279% (hemodilution to Hb 2.4 g/dl) and had a tendency to decrease during hemodilution from Hb 1.5 g/dl to Hb crit -1.0.
However, during the entire hemodilution protocol, LAD flow remained increased. Consistently with the decrease of SVRI, coronary perfusion pressure (CPP) decreased continuously beyond baseline level. While DO 2 to the LAD-supplied myocardium (mDO 2 ) decreased continuously, myocardial O 2 ER and VO 2 remained almost unaltered. However, coronary venous lactate concentration was significantly increased at Hb crit -1.0, indicating compromised myocardial lactate extraction and aerobic capacity.
Discussion
The main result of the present study is that HV with FiO 2 1.0 only provided a marginal increase of anemia tolerance as compared to animals ventilated with FiO 2 0.6 in our previous study [7] . This is indicated by a slightly lower value of Hb crit (1.3 ± 0.3 vs. 1.6 ± 0.4 g/dl) and a higher volume of blood exchanged for HES (3,749 ± 640 vs. 2,634 ± 407 ml).
Regarding secondary endpoints ( table 2 ) , animals ventilated with pure oxygen appeared slightly superior to animals ventilated with FiO 2 0.6 regarding the following criteria: first, they presented less tachycardiac and less hypotensive at Hb crit -0.21. However, at their individual Hb crit , cardiovascular performance was equally impaired. Second, the increase of lactate appeared attenuated and pvO 2 tended to be higher at any time point. Third, at Hb crit -0.6, myocardial perfusion appeared less compromised.
Proportionally with FiO 2 , HV increases the amount of O 2 physically dissolved in the plasma. This effect gains importance in profound anemia, as the contribution of red blood cells to O 2 transport is declining and the significance of the plasma compartment as an O 2 reservoir is increasing. At the site of microcirculation, physically dissolved O 2 is utilized more readily than Hb-bound O 2 , since plasma and red blood cells are separated in such a manner that the inner vascular wall is covered with a plasma layer. During HV, the utilization of physically dissolved O 2 is additionally favored due to the elevated gradient of O 2 partial pressure to the interstitium [11, 12] . The actual utilization of physically dissolved O 2 is reflected by our data, as HV with pure O 2 significantly increased the contribution of physically dissolved O 2 to DO 2 and VO 2 ( fig. 4 a, b) .
HV with FiO 2 1.0 did not result in a substantially lower Hb crit when compared to FiO 2 0.6 (1.3 vs. 1.5 g/dl). However, the absolutely lowest values of Hb crit were observed in 2 animals ventilated with FiO 2 1.0, which met Hb crit at 0.8 g/dl. Moreover, a more extensive blood-for-HES exchange was necessary for institution of Hb crit than in animals ventilated with FiO 2 0.6. Hb crit marks the ultimate limit of anemia tolerance [5, 13] ; without further treatment (e.g. elevation of FiO 2 , transfusion of red blood cells or infusion of artificial O 2 carriers), hemodilution to Hb crit is associated with 100% mortality [14] [15] [16] . Hb crit therefore reflects the limit of anemia tolerance at the level of the whole organism by averaging VO 2 of all organs. However, this approach disregards the cellular and organ-specific level of anemia tolerance. A recent study investigated the limits of anemia tolerance of the heart, the brain, the kidneys, the liver, Data excerpted from our previous study [7] . For abbreviations, see text and table 1. * p < 0.05 vs. baseline; § p < 0.05 vs. group 0.21. the small intestine and the skeletal muscle. Especially in the kidneys and in the skeletal muscle, signs of tissue hypoxia were observed before the critical limit of systemic O 2 supply was reached [17] .
Although neglecting the organ-specific level of anemia tolerance may be judged as a limitation of the present experimental model, the assessment of total-body Hb crit has been used in several experimental hemodilution studies. In particular, a reduction of Hb crit could be achieved by hypothermia (moderate reduction of body core temperature reduces total body O 2 demand [18] ), infusion of norepinephrine (stabilization of CPP during hemodilution [19] ), infusion of artificial O 2 carriers (maintenance of CaO 2 despite reduced hematocrit [20, 21] ) and continuous NMB (lowering skeletal muscular O 2 demand [22] ).
Notably, in paralyzed animals, Hb crit was found about 1 g/dl lower than in animals without NMB. NMB was used in the present study as well as in our previous study [7] to eliminate muscular activity and thereby to enable exact performance of tpO 2 measurement.
Moreover, the choice of the infusion fluid used for hemodilution has an impact on Hb crit . While the use of HES in the clinical setting is presently a matter of controversy, mid-molecular HES preparations have at least in the experimental setting proven effective regarding the maintenance of tissue oxygenation in profound anemia and were in this respect superior to gelatin or to crystalloids [23] . The advantages of HES 130/0.4 were explained with a lower degree of extravasation resulting in a more sustained volume effect and reduced tissue edema formation.
Hemodilution and hyperoxia have antipodal effects on microvascular resistance. Accelerated blood flow increases shear stress at the endothelial vascular layer, resulting in the release of nitrous oxide and vasodilation [24, 25] . These effects are, however, counteracted by hyperoxic vasoconstriction, which has been observed in large vessels as well as in microvessels (arterioles, venules) [26, 27] . While these effects are balanced at moderate degrees of anemia, stages of profound anemia are characterized by hypotension. When blood viscosity and, thus, intracapillary blood pressure fall below the hydrostatic pressure of the capillary-surrounding tissue, microvascular collapse is imminent [28, 29] .
In the present study, microvascular collapse is indicated by the extreme left shift of the tpO 2 histograms, which occurred despite the significant portion of physically dissolved O 2 to O 2 supply. Impaired microvascular perfusion is also reflected by global indicators of tissue hypoxia (decreasing base excess and pH, increasing lactate concentration). As single organs have not been investigated in the present study, it is neither possible to localize potential origins of lactate production, nor to distinguish the degree of tissue hypoxia within particular organs.
Moreover, at their individual Hb crit , animals subjected to HV were more hypotensive than animals ventilated with ambient air. At extremely low Hb concentrations, myocardial oxygenation became compromised by anemic hypoxia as well as by decreasing CPP. As a consequence, cardiac output declines, resulting in a decrease of coronary blood flow and a further limitation of myocardial perfusion.
The onset of this vicious circle not only accelerates the breakdown of hemodynamic compensation, thereby directly decreasing VO 2 . This implies that at extremely low Hb levels, the primary endpoint of the experimental protocol is influenced by effects beyond limited O 2 transport capacity, which should be judged as a weakness of our experimental model. However, at Hb crit -0.21, VO 2 was obviously not affected by circulatory failure, so that our main conclusion remains applicable, namely that HV with either FiO 2 increased anemia tolerance and therefore enabled continuation of hemodilution to Hb values below 2.4 g/dl (i.e. Hb crit -0.21).
The present study was motivated by the fact that in our previous study, FiO 2 had to be restricted to 0.6 for methodological reasons; the endpoint of the hemodilution protocol (i.e. the onset of O 2 supply dependency of VO 2 ) was assessed with a Deltatrac TM II metabolic monitor (Datex-Engström, Helsinki, Finland) [7] . This device calculates VO 2 as the quotient of CO 2 production (VCO 2 ) and the respiratory quotient (RQ), the latter being calculated with the Haldane transformation (see Appendix). As this algorithm yields implausible results when FiO 2 exceeds a maximum of 0.65, the institution of FiO 2 1.0 is impossible using the Deltatrac II metabolic monitor [30] . Therefore, the question remained open whether a further increase of FiO 2 from 0.6 to 1.0 would additionally increase the tolerance of acute normovolemic anemia.
At a later time point, the Oxycon Pro device became available. The algorithm of this device is based on the measurement of expiratory O 2 and CO 2 fractions with a paramagnetic and an infrared absorption sensor, respectively. According to the manual, the accuracy of measurement is 3% or 0.05 l/min, respectively. However, the Oxycon Pro device exerts a modified Haldane transformation, which allows assessment of VO 2 even during HV with pure oxygen, providing that the system has been calibrated with FiO 2 1.0. Although this algorithm underwent an in-house validation by the manufacturer, it has neither been published in detail so far, nor has it been validated against other techniques (e.g. reverse Fick principle). While the validity and reliability of VO 2 assessment with the Oxycon Pro device has already been investigated under normoxic conditions [31] , this device was used in a recently published study investigating the effects of HV (FiO 2 1.0) on VO 2 and RQ in healthy spontaneously breathing volunteers [32] .
In the setting of experimental hemodilution, the Oxycon Pro device enabled us for the first time to assess VO 2 even during HV with pure oxygen. With respect to the number of experimental animals and for ethical reasons, we decided to only perform the present 7 experiments and to use the results of the previous study in terms of 2 historical reference groups.
Our data demonstrate that HV with pure O 2 only provides a marginal gain of anemia tolerance as compared with FiO 2 0.6. Overall, the extensive blood-for-HES exchange until the onset of O 2 supply dependency implies that HV allows to delay the transfusion of red blood cells, e.g. in case of bridging an acute blood loss until blood products become available. However, while the lack of O 2 carriers can be compensated by physically dissolved O 2 in extreme anemia (i.e. Hb concentrations <2 g/dl), O 2 transport becomes additionally impaired by cardiovascular collapse and microvascular perfusion disorders. Despite the excellent bioavailability of physically dissolved O 2 , the management of extreme normovolemic anemia might require a multimodal approach including the choice of the optimal infusion fluid, deep NMB and circulatory support with catecholamines [1] . HV with FiO 2 1.0 might temporarily be useful; however, HV with FiO 2 0.6 has equipotent effects on maintaining O 2 supply to the tissues. For induction and maintenance of anesthesia, the following drugs were used: ketamine (Ketavet TM , Parke-Davis, Berlin, Germany); midazolam (Midazolam TM , Ratiopharm, Ulm, Germany); propofol (Brevimytal TM , Braun, Bad Melsungen, Germany); fentanyl (Fentanyl TM , Janssen, Neuss, Germany); pancuronium (Pancuronium TM , Curamed, Karlsruhe, Germany); balanced electrolyte solution (Tutofusin TM , Pharmacia, Erlangen, Germany), and HES 130/0.4 (Voluven TM , Fresenius Kabi, Bad Homburg, Germany).
